Ligand Pharmaceuticals Incorporated

LGND Healthcare Delisted
$113.3 +$0.74 (0.66%)
Market Cap: $2.19 B
Gurus Holding
7
Popularity Rank
#N/A
% of Shares Held
83.54%
Net Activity (Q3 2025)
+$22.56 M

Guru Ownership Over Time

Guru Analysis for Ligand Pharmaceuticals Incorporated (LGND)

Ligand Pharmaceuticals Incorporated (LGND), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q3 2025, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.83 B.

Top institutional holders include Private Capital and Ken Fisher.

Institutional sentiment is currently Bullish. This is evidenced by a $22.56 M net inflow during the quarter.

Recent activity highlights Paul Tudor Jones who opened a new position. Conversely, Private Capital reduced exposure by 0.9%.

Portfolio Manager % of portfolio Activity Shares Value Peroid
3.59% Reduce -0.9% 227,158 $40.24 M Q3 2025
0.01% Add 2.7% 108,926 $19.3 M Q3 2025
0.03% New Buy 15,750,000 $17.7 M Q3 2025
0.00% New Buy 16,700 $2.96 M Q3 2025
0.01% New Buy 9,475 $1.68 M Q3 2025
0.00% Add 36.5% 4,584 $812,010 Q3 2025
0.00% New Buy 1,288 $228,156 Q3 2025

Key Holders

Top 5 by Value

$40.24 M
$19.3 M
$2.96 M
$1.68 M

Top 5 by Conviction

Recent Activity Breakdown(Q3 2025)

+$23.29 M
Total Buy Value
New Buys: 4
Additions: 2
-$728,063.3
Total Sell Value
Reductions: 1
Sold Out: 1

Guru Consensus (Q3 2025)

Based on recent guru activity
Net Sellers
2
Net Buyers
6

FAQs for Ligand Pharmaceuticals Incorporated (LGND)

Top Guru holders include Private Capital ($40.24 M), Ken Fisher ($19.3 M), Paul Tudor Jones ($17.7 M). Collectively, tracked Gurus hold 16.12 M shares.

Based on recent 13F filings, the sentiment is **Positive (Net Buy)**. There was a net inflow of $22.56 M, with 6 Gurus buying and 2 Gurus selling.

In the recent quarter, 1 Gurus reduced their positions, and 1 Gurus sold out of LGND completely. Total sell value was $728,063.3.

Yes, 4 Gurus opened new positions in LGND, and 2 added to their existing holdings. Total buy value was $23.29 M.